Compare Cardlytics, Inc. with Similar Stocks
Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -2.14% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.13
2
Flat results in Sep 25
3
Risky -
4
Below par performance in long term as well as near term
Stock DNA
Computers - Software & Consulting
USD 38 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-36.63
1,100.83%
-8.16
Revenue and Profits:
Net Sales:
56 Million
(Quarterly Results - Dec 2025)
Net Profit:
-8 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.32%
0%
-18.32%
6 Months
-70.05%
0%
-70.05%
1 Year
-64.89%
0%
-64.89%
2 Years
-93.68%
0%
-93.68%
3 Years
-73.56%
0%
-73.56%
4 Years
-98.48%
0%
-98.48%
5 Years
-99.33%
0%
-99.33%
Cardlytics, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.84%
EBIT Growth (5y)
-2.14%
EBIT to Interest (avg)
-12.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.55
Sales to Capital Employed (avg)
0.85
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
63.10%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-8.16
EV to EBIT
-4.23
EV to EBITDA
-9.11
EV to Capital Employed
1.26
EV to Sales
0.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-29.73%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Bearish
Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 33 Schemes (14.89%)
Foreign Institutions
Held by 56 Foreign Institutions (9.53%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
56.10
74.00
-24.19%
Operating Profit (PBDIT) excl Other Income
1.00
-1.70
158.82%
Interest
3.00
2.40
25.00%
Exceptional Items
-0.60
-0.10
-500.00%
Consolidate Net Profit
-8.20
-15.60
47.44%
Operating Profit Margin (Excl OI)
-98.70%
-111.00%
1.23%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is -24.19% vs -17.04% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 47.44% vs 84.52% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
233.30
278.30
-16.17%
Operating Profit (PBDIT) excl Other Income
-19.70
-35.70
44.82%
Interest
10.60
8.90
19.10%
Exceptional Items
-59.50
-118.90
49.96%
Consolidate Net Profit
-103.50
-189.30
45.32%
Operating Profit Margin (Excl OI)
-202.10%
-228.30%
2.62%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -16.17% vs -9.99% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 45.32% vs -40.53% in Dec 2024
About Cardlytics, Inc. 
Cardlytics, Inc.
Computers - Software & Consulting
Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The Company delivers relevant and measurable marketing analysis with purchase data from over financial institutions. The purchase data includes debit, credit, and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions (FI). It provides personalized offers and suggestions for FI consumers on their purchase.
Company Coordinates 
Company Details
675 Ponce de Leon Ave NE , ATLANTA GA : 30308-1884
Registrar Details






